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BACKGROUND
The rate of teenage pregnancy in the United States is higher than in other developed 
nations. Teenage births result in substantial costs, including public assistance, health 
care costs, and income losses due to lower educational attainment and reduced 
earning potential.
METHODS
The Contraceptive CHOICE Project was a large prospective cohort study designed to 
promote the use of long-acting, reversible contraceptive (LARC) methods to reduce 
unintended pregnancy in the St. Louis region. Participants were educated about 
reversible contraception, with an emphasis on the benefits of LARC methods, were 
provided with their choice of reversible contraception at no cost, and were followed 
for 2 to 3 years. We analyzed pregnancy, birth, and induced-abortion rates among 
teenage girls and women 15 to 19 years of age in this cohort and compared them 
with those observed nationally among U.S. teens in the same age group.
RESULTS
Of the 1404 teenage girls and women enrolled in CHOICE, 72% chose an intrauter-
ine device or implant (LARC methods); the remaining 28% chose another method. 
During the 2008–2013 period, the mean annual rates of pregnancy, birth, and abor-
tion among CHOICE participants were 34.0, 19.4, and 9.7 per 1000 teens, respectively. 
In comparison, rates of pregnancy, birth, and abortion among sexually experienced 
U.S. teens in 2008 were 158.5, 94.0, and 41.5 per 1000, respectively.
CONCLUSIONS
Teenage girls and women who were provided contraception at no cost and edu-
cated about reversible contraception and the benefits of LARC methods had rates 
of pregnancy, birth, and abortion that were much lower than the national rates for 
sexually experienced teens. (Funded by the Susan Thompson Buffett Foundation and 
others.)
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A lthough it has declined substan-tially over the past two decades, the preg-nancy rate among girls and women 15 to 
19 years of age remains a stubborn public health 
problem. Each year, more than 600,000 teens be-
come pregnant, and 3 in 10 teens will become 
pregnant before they reach 20 years of age.1,2 Rates 
are higher among black and Hispanic teens, with 
4 in 10 becoming pregnant by 20 years of age, as 
compared with 2 in 10 white teens.2-4 In addition 
to the negative health and social consequences 
borne by teenage mothers and their children, the 
national financial burden is substantial. In 2010, 
births involving teenage mothers cost the United 
States nearly $10 billion in increased public as-
sistance and health care and in income lost as a 
result of lower educational attainment and re-
duced earnings among children born to teenage 
mothers.5
The President’s Teen Pregnancy Prevention Ini-
tiative was launched in 2010 to address the high 
teenage pregnancy rate by replicating evidence-
based models and innovative strategies.6 Teen-
age pregnancy has also been designated by the 
Centers for Disease Control and Prevention (CDC) 
as one of the six Winnable Battles because of the 
magnitude of the problem and the belief that it 
can be addressed by strategies that are known to 
be effective.7 The Winnable Battle target is to re-
duce the teenage birth rate by 20%, from 37.9 
births per 1000 teens in 2009 to 30.3 per 1000 
by 2015.
Long-acting, reversible contraceptive (LARC) 
methods, which include intrauterine devices 
(IUDs) and implants, have been shown to be ac-
ceptable to teens and young women, with higher 
continuation rates than shorter-acting methods.8,9 
LARC methods reduce the likelihood of preg-
nancy and of repeat pregnancy among adoles-
cents,10,11 yet less than 5% of U.S. teens report 
using LARC methods.12
Lack of information about effective contracep-
tion, limited access, and cost remain barriers to 
the use of LARC methods by teens.13-15 It is unclear 
whether removal of these barriers can reduce un-
intended pregnancy and birth rates among high-
risk, sexually active teens. We assessed pregnan-
cy, birth, and abortion rates in a cohort of teens 
among whom these three barriers to highly ef-
fective reversible contraception were removed, 
and we compared these rates with rates observed 
nationally among all teens in the United States.
Me thods
Study Enrollment
The Contraceptive CHOICE Project was a prospec-
tive cohort study involving 9256 St. Louis area 
girls and women 14 to 45 years of age, in which 
the use of LARC methods was promoted to re-
duce unintended pregnancy.16 Participants were 
recruited through referral from medical providers, 
word of mouth, and study flyers. The Washing-
ton University School of Medicine in St. Louis 
Human Research Protection Office approved the 
study protocol before recruitment began, and all 
participants provided written informed consent. 
Participants 14 to 17 years of age provided writ-
ten assent, and a parent or guardian provided 
written consent. Minors could enroll under a 
waiver of parental consent if they did not know 
the whereabouts of their parents or guardians or 
if they did not want their parents or guardians 
to know that they were seeking contraception. 
We enrolled four minors using the waiver.
Women and adolescent girls were eligible to 
participate in CHOICE if they were English-speak-
ing or Spanish-speaking, resided in the St. Louis 
region or sought contraceptive services in selected 
community clinics, had no desire for pregnancy for 
at least 12 months, were sexually active or plan-
ning to be sexually active with a male partner dur-
ing the next 6 months, and were not using a con-
traceptive method or were willing to switch to a 
new, reversible contraceptive method. Women and 
adolescent girls were ineligible if they had under-
gone a hysterectomy or sterilization procedure.
Study Design
CHOICE provided standardized contraceptive 
counseling to study participants regarding com-
monly used reversible contraceptive methods.17 
Methods were presented in order from most to 
least effective, and the potential side effects, 
risks, and benefits of each method were reviewed. 
Participants were provided with their chosen 
method at their enrollment session in accor-
dance with evidence-based clinical guidelines.18,19 
If medical contraindications did not allow for 
same-day insertion of a LARC device (e.g., if preg-
nancy could not be ruled out definitively or if the 
participant had active cervicitis), participants re-
ceived a shorter-acting method, such as oral con-
traceptive pills or depot medroxyprogesterone 
acetate (DMPA) injection, until their chosen meth-
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od could be initiated. During the enrollment ses-
sion, study staff performed a baseline interview, 
and participants were screened for sexually trans-
mitted infections.
Participants were followed for 2 to 3 years, 
depending on their enrollment date. Telephone 
interviews were administered by study staff at 
3 and 6 months and every 6 months thereafter. 
Participants received a $10 gift card after every 
completed follow-up survey. During the baseline 
and follow-up surveys, we collected detailed in-
formation regarding demographic characteristics 
and reproductive history, including contraceptive 
method use and satisfaction, sexual behavior, 
and pregnancy.
This analysis involves the 1404 adolescents 
who enrolled in CHOICE between 14 and 19 years 
of age, from 2007 through 2011; 716 teens were 
followed for 3 years, and 688 teens were followed 
for 2 years. At each follow-up survey, we asked 
participants if they had had a pregnancy. Par-
ticipants who contacted study staff outside a 
scheduled survey or came to the clinic with con-
cerns about possible pregnancy completed a urine 
pregnancy test. We recorded all pregnancies in a 
pregnancy log and documented the contraceptive 
method used at the time of conception. If the 
outcome of the pregnancy was known at the time 
of the survey (e.g., birth, miscarriage, or abortion), 
it was documented in the pregnancy log. If a par-
ticipant was currently pregnant, we subsequently 
contacted her to record the pregnancy outcome.
Study Outcomes
The primary outcomes of the study were the rates 
of pregnancy, live birth, and induced abortion 
observed among participants who were 15 to 19 
years of age at any time during study participa-
tion. We compared the rates in the CHOICE co-
hort with the most recent available rates among 
all U.S. teens 15 to 19 years of age, from 2010,1 
and hypothesized that the rates in CHOICE 
would be lower than the national rates. Because 
the U.S. rates represent all teenage girls and 
women 15 to 19 years of age, including those 
who are and those who are not sexually experi-
enced, we also compared the CHOICE rates with 
the national rates reported among sexually expe-
rienced teenage girls and women in 2008 (the 
most recent available data).20 In addition, we ex-
amined rates according to age and race as second-
ary outcomes. All analyses of rates of pregnancy, 
live birth, and induced abortion; teen-years of use 
of contraceptive methods; and failure rates of con-
traceptive methods included data collected when 
members of the cohort were 15 to 19 years of age.
Statistical Analysis
We used frequencies, percentages, medians, and 
ranges to describe the demographic and repro-
ductive characteristics of the participants at the 
time of study enrollment. A chi-square test was 
performed for categorical data, and a Wilcoxon 
two-sample test was performed for continuous 
data that was not normally distributed.
For this analysis, we calculated annual means 
and 95% confidence intervals for rates of preg-
nancy, live birth, and induced abortion from 2008 
through 2013, because the number of pregnan-
cies and pregnancy outcomes that occurred among 
teenage CHOICE participants each year was small. 
Each rate represents the total number of events 
(i.e., pregnancy, birth, or abortion) that occurred 
among the participants divided by the total 
amount of time contributed from 2008 through 
2013. For a pregnancy to be considered in the 
analysis, the outcome of the pregnancy (i.e., birth 
or abortion, for the purposes of this study) had 
to occur before 20 years of age. This is the same 
approach used by the National Center for Health 
Statistics in calculating U.S. rates.1 We calculat-
ed the time contributed by each participant dur-
ing which she was not pregnant. If at the last 
survey the participant reported she had not been 
pregnant since the previous contact, we subtract-
ed 6 weeks of contributed time to account for the 
possibility of an early-stage and unknown preg-
nancy. For a participant who had a pregnancy, 
we subtracted the total time she was pregnant 
plus 1 month if she delivered, to account for post-
partum infecundity. For participants who were 
lost to follow-up, the last date of contact was the 
cutoff point for outcomes and contributed time. 
All analyses were performed with the use of 
Stata software, version 11 (StataCorp).
R esult s
Characteristics of the Participants
Table 1 gives the baseline demographic and re-
productive characteristics of the 1404 teenage 
participants, stratified by age group at enrollment 
(14 to 17 years vs. 18 to 19 years). Nearly 500 
minors 14 to 17 years of age were enrolled in the 
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study. Nearly half the participants reported a 
previous unintended pregnancy, and 18% had a 
history of abortion. As compared with younger 
teens, those who were 18 to 19 years of age re-
ported more lifetime male sex partners and greater 
parity and had a higher frequency of previous 
sexually transmitted infections. The majority of 
teens in both age groups chose LARC methods, 
but teens 14 to 17 years of age were more likely 
than older teens to do so (77.5% vs. 68.4%, P<0.001). 
The implant was the most common contraceptive 
choice for participants 14 to 17 years of age, 
whereas an IUD was most commonly chosen by 
older teens (Table 1).
Pregnancy, Birth, and Abortion Rates
The 12-month, 24-month, and 36-month follow-
up rates among CHOICE participants were 92%, 
82%, and 75%, respectively. During 1738 teen-
years of follow-up between 2008 and 2013, teens 
in the CHOICE cohort reported 56 pregnancies, 





 of Age 
(N = 484)
18–19 Years 
 of Age 
(N = 920) P Value*
Race — no. (%)† <0.01
Black 877 (62.5) 328 (67.8) 549 (59.7)
White 416 (29.6) 119 (24.6) 297 (32.3)
Other 111 (7.9) 37 (7.6) 74 (8.0)
Low socioeconomic status — no. (%)‡ 623 (44.4) 163 (33.7) 460 (50.0) <0.01
Health insurance — no./total no. (%) <0.01
None 392/1361 (28.8) 78/453 (17.2) 314/908 (34.6)
Private 583/1361 (42.8) 218/453 (48.1) 365/908 (40.2)
Public 386/1361 (28.4) 157/453 (34.7) 229/908 (59.3)
Lifetime male sex partners — median no. (range) 3.0 (0–175) 2.0 (0–30) 3.0 (0–175) <0.01
Parity — no. (%) <0.01
0 1059 (75.4) 397 (82.0) 662 (72.0)
1 289 (20.6) 79 (16.3) 210 (22.8)
≥2 56 (4.0) 8 (1.7) 48 (5.2)
Previous unintended pregnancy — no./total no. (%) 671/1403 (47.8) 219/484 (45.2) 452/919 (49.2) 0.16
History of abortion — no. (%) 259 (18.4) 70 (14.5) 189 (20.5) <0.01
History of sexually transmitted infection — no. (%)§ 331 (23.6) 88 (18.2) 243 (26.4) <0.01
Baseline chosen contraceptive method — no. (%)¶ <0.01
Hormonal IUD 445 (31.7) 119 (24.6) 326 (35.4)
Nonhormonal IUD 75 (5.3) 14 (2.9) 61 (6.6)
Etonogestrel implant 485 (34.5) 242 (50.0) 243 (26.4)
DMPA injection 127 (9.0) 51 (10.5) 76 (8.3)
Oral contraceptive pill 175 (12.5) 39 (8.1) 136 (14.8)
Ring 69 (4.9) 11 (2.3) 58 (6.3)
Patch 28 (2.0) 8 (1.7) 20 (2.2)
*  P values are for the comparison between the age groups (14 to 17 vs. 18 to 19 years of age).
†  Race was self-reported.
‡  Participants were classified as having low socioeconomic status if they reported current receipt of food stamps; vouchers from the Special 
Supplemental Nutrition Program for Women, Infants, and Children; other welfare benefits; unemployment benefits; or difficulty in paying 
for transportation, housing, health or medical care, or food.
§  Data are based on a self-reported history of chlamydia infection, gonorrhea, or trichomoniasis.
¶  DMPA denotes depot medroxyprogesterone acetate, and IUD intrauterine device.
Table 1. Baseline Characteristics of Study Participants Overall and According to Age Group.
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and 1 stillbirth. Reported methods used at the 
time of conception included the levonorgestrel 
IUD (2 participants), DMPA injection (1), oral con-
traceptive pills (13), the ring (4), the patch (2), 
condoms (9), and no method (25). The teen-
years of use and failure rates of contraceptive 
methods among the participants using these 
methods were as follows: 394.2 teen-years and 
5.1 failures per 1000 teen-years for the levonor-
gestrel IUD, 193.8 teen-years and 5.2 failures per 
1000 teen-years for DMPA injection, 229.0 teen-
years and 56.8 failures per 1000 teen-years for 
oral contraceptive pills, 77.2 teen-years and 51.8 
failures per 1000 teen-years for the contraceptive 
ring, and 32.9 teen-years and 60.8 failures per 
1000 teen-years for the contraceptive patch. No 
pregnancies occurred with the copper IUD (57.3 
teen-years) or the etonogestrel subdermal implant 
(633.3 teen-years).
Table 2 gives the overall rates of pregnancy, 
live birth, and induced abortion in the CHOICE 
teenage cohort; respective rates for teens in the 
United States in 2010 are provided for compari-
son. The mean annual rates were 34.0 per 1000 
teens (95% confidence interval [CI], 25.7 to 44.1), 
19.4 per 1000 (95% CI, 13.3 to 27.4), and 9.7 per 
1000 (95% CI, 5.6 to 15.8), respectively. The cor-
responding 2010 rates among U.S. teens nation-
ally were 57.4, 34.4, and 14.7 per 1000.
Among teenage girls and women enrolled in 
CHOICE, 97% were sexually experienced at base-
line, and 99% were sexually experienced by 12 
months of follow-up. Thus, Table 2 also presents 
a comparison of the mean annual rates in CHOICE 
as compared with 2008 U.S. rates representing 
only sexually experienced teens. The pregnancy, 
birth, and abortion rates per 1000 sexually expe-
rienced U.S. teens in 2008 were 158.5, 94.0, and 
41.5, respectively.
Figure 1 shows the pregnancy, birth, and abor-
tion rates among CHOICE participants, as com-
pared with the 2010 rates among all U.S. teens. 
The rates were stratified according to age group 
and race. For all three outcomes within each 
stratum, the rates among CHOICE participants 
were lower than the U.S. rates. The difference 
between rates in CHOICE and national rates was 
greater for those 18 to 19 years of age and 
among black teens. Figure 2 shows the pregnancy 
rates among CHOICE teens, as compared with 
sexually experienced U.S. teens, according to age 
group and race. For both age groups and both 
races, the CHOICE rates were substantially lower 
than the national rates.
Discussion
We found that pregnancy, birth, and abortion rates 
were low among teenage girls and women en-
rolled in a project that removed financial and 
access barriers to contraception and informed 
them about the particular efficacy of LARC meth-
ods. The observed rates of pregnancy, birth, and 
abortion were substantially lower than national 
rates among all U.S. teens, particularly when 
compared with sexually experienced U.S. teens. 
Stratification according to factors known to be 
associated with sexual behavior and pregnancy 
risk (age and race)21 showed that this was true 
among both older teens (18 to 19 years of age) and 
younger teens, as well as among both white 
and black teens.
The CDC Winnable Battle 2015 goal for teen-
age births is 30.3 per 1000 teens. The mean 
annual teenage birth rate in our cohort was 19.4 
per 1000 teens, 36% lower than the 2015 goal. 
Our teenage pregnancy and birth rates reflect 
teens using highly effective contraception, with 
a high rate of LARC use in this cohort (i.e., 72% 
overall among teens). Although the rate of LARC 
use among teens 15 to 19 years of age in the 
United States has increased from less than 1% in 
2002 to almost 5% in 2009, our study suggests 
that it is possible to achieve a much greater rate 
of use.12 Furthermore, teens in our cohort con-








no. per 1000 teens
mean no. per  
1000 teens  
(95% CI)
Pregnancy 57.4 158.5 34.0 (25.7–44.1)
Birth 34.4 94.0 19.4 (13.3–27.4)
Abortion 14.7 41.5 9.7 (5.6–15.8)
*  Data are U.S. rates for the year 2010.1
†  Data are U.S. rates for the year 2008.20
‡  Data are the mean annual rates for the years 2008 through 2013. CI denotes 
confidence interval.
Table 2. Pregnancy, Birth, and Abortion Rates among Girls and Women 15 
 to 19 Years of Age in the CHOICE Cohort as Compared with Those in the 
U.S. Population.*
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er-acting methods such as the oral contraceptive 
pill and DMPA injection; two thirds of teens in 
CHOICE were still using their LARC method at 
24 months of follow-up, as compared with only 
one third of teens using a non-LARC method.8
The limitations of our study must be consid-
ered. First, information about pregnancy was 
self-reported by participants, and thus it is pos-
sible that the number of teenage pregnancies 
was underestimated in the CHOICE cohort. The 
U.S. pregnancy statistics rely on a composite of 
birth data, the abortion surveillance system, and 
self-reporting to estimate pregnancy rates. Sec-
ond, teens were surveyed on a regular basis re-
garding their contraceptive method use, which 
may have influenced adherence to their contra-
ceptive method. Third, the generalizability of our 
results is uncertain. Teens in CHOICE received 
standardized contraceptive counseling during 
which methods were presented in order from 
most to least effective. This counseling approach 
may differ from the usual counseling that teens 
receive in the United States but could certainly 
be applied in routine practice. Fourth, the enroll-
ment of minors in CHOICE required parental 
consent. Most teens can access confidential con-
traceptive services without parental notification 
or consent, regardless of age. Minors who en-
rolled in CHOICE with the consent of their par-
ent or guardian may represent a group of teens 
at lower risk for contraceptive nonuse and preg-
nancy.22 However, as compared with teens nation-
ally, the teens enrolled in CHOICE are at greater 
risk for unintended pregnancy; 60% of the par-
ticipants are black (vs. 16% of female teens 15 to 
19 years of age in the United States),23 and al-
most all had had sexual intercourse at the time 
of enrollment, with nearly three quarters report-
ing sexual intercourse in the previous 30 days 
(vs. national frequencies of 43% and one quarter, 
respectively).21
A final limitation is that we compared a mean 
annual rate for the period from 2008 through 
2013 with 2010 national rates. From 2008 to 
2010, the pregnancy rate declined by 15% among 
all teens in the United States. The most recent 
birth data (2012) indicate that the birth rate 
among teens 15 to 19 years of age dropped to 
29.4 per 1000, the lowest rate ever reported for 
the United States.24 (Data on national pregnancy 
and abortion rates are not yet available beyond 
2010.) Even with this continued decline, the re-
ductions observed in CHOICE are substantial 
and of public health importance.
In summary, we found that in a cohort of teen-
age girls and women for whom barriers to con-
Figure 1. Pregnancy, Birth, and Abortion Rates among U.S. Teenage Girls 
and Women, as Compared with CHOICE Participants, Stratified According 
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traception (lack of knowledge, limited access, 
and cost) are removed and the use of the most 
effective contraceptive methods is encouraged, a 
large percentage opted to use LARC methods. 
The rates of pregnancy, birth, and abortion in 
our cohort were below both the most recent cor-
responding national rates and the CDC Winnable 
Battle 2015 goal.
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